Literature DB >> 33655296

Inclisiran: a new milestone on the PCSK9 road to tackle cardiovascular risk.

Gaetano Santulli1,2,3, Stanislovas S Jankauskas1,2, Jessica Gambardella1,2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33655296     DOI： 10.1093/ehjcvp/pvab014

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Pharmacother


× No keyword cloud information.
  3 in total

1.  Synergistic effect of the commonest residual risk factors, remnant cholesterol, lipoprotein(a), and inflammation, on prognosis of statin-treated patients with chronic coronary syndrome.

Authors:  Hui-Hui Liu; Yuan-Lin Guo; Cheng-Gang Zhu; Na-Qiong Wu; Ying Gao; Rui-Xia Xu; Qian Dong; Jie Qian; Ke-Fei Dou; Jian-Jun Li
Journal:  J Transl Med       Date:  2022-05-26       Impact factor: 8.440

2.  Comparative Effect of Bergamot Polyphenolic Fraction and Red Yeast Rice Extract in Rats Fed a Hyperlipidemic Diet: Role of Antioxidant Properties and PCSK9 Expression.

Authors:  Rocco Mollace; Roberta Macrì; Annamaria Tavernese; Micaela Gliozzi; Vincenzo Musolino; Cristina Carresi; Jessica Maiuolo; Massimo Fini; Maurizio Volterrani; Vincenzo Mollace
Journal:  Nutrients       Date:  2022-01-22       Impact factor: 5.717

3.  Omega-3 fatty acids coordinate glucose and lipid metabolism in diabetic patients.

Authors:  Pasquale Mone; Fahimeh Varzideh; Urna Kansakar; Carmine Infante; Angela Lombardi; Antonio de Donato; Salvatore Frullone; Gaetano Santulli
Journal:  Lipids Health Dis       Date:  2022-03-25       Impact factor: 3.876
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.